9 June 2020 - Expanded Access Program provides pathway for patients to gain access to treatment with onvansertib outside of clinical ...
27 September 2019 - Novartis’ AveXis unit has given its reasons for refusing to supply its spinal muscular atrophy gene ...
10 August 2017 - In mid-July, the nonpartisan research arm of the federal government, the Government Accountability Office, released its long-awaited ...
11 October 2016 - As patients clamour for greater access to experimental medicines, a survey released Tuesday finds that ...
2 June 2016 - Today, the U.S. FDA finalized its efforts to streamline the process used by physicians to request expanded ...